Clinical Trial Update: Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

View source ↗

Summary

Clinical trial update evaluating the performance of the Histidine Rich Protein 2 Highly Sensitive Rapid Diagnostic Test for diagnosing malaria in pregnant women…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: Foundation for Innovative New Diagnostics, Switzerland | Conditions: Plasmodium Falciparum Malaria, Pregnancy Malaria | Status: UNKNOWN